The Future of the ACA and Plans to Repeal: Dr Patricia Salber Interviews Dr Joe Antos

There are a lot of unknowns about how Republicans will move to repeal and replace the Affordable Care Act now that they will have a Republican in the White House. Joe Antos, PhD, resident scholar at the American Enterprise Institute, did his best to speculate how a repeal might play out and what will happen with Medicaid expansion under a Trump presidency.

Related Videos

Related Content

Advertisement

July 25th 2025

Contributor: When AI Sees, Yet Cannot Judge—Why Health Care Must Remain Human-Led

Andy Truscott

Although artificial intelligence (AI) is quickly becoming a tool used in health care, the human aspect of health care is still necessary for continued care.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 23rd 2025

Insulin Nasal Spray Reaches Memory Centers in Brain, Offering Hope for Alzheimer Treatment

Hayden E. Klein

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older adults.

July 23rd 2025

The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD

Maggie L. Shaw Miriam Freimer, MD

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice and looks to the future of treatment for the autoimmune neuromuscular disorder.

Related Content

Advertisement

July 25th 2025

Contributor: When AI Sees, Yet Cannot Judge—Why Health Care Must Remain Human-Led

Andy Truscott

Although artificial intelligence (AI) is quickly becoming a tool used in health care, the human aspect of health care is still necessary for continued care.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

July 24th 2025

Prevalence and Inclusiveness of Pay-for-Performance Incentives for HPV Vaccination

Justin G. Trogdon, PhD Kathryn R. Brignole, MS Ben Fogel, MD, MPH Tara Licciardello Queen, PhD

This article examines the prevalence of pay-for-performance incentives to promote human papillomavirus vaccination and other quality metrics as reported by frontline clinical staff.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 23rd 2025

Insulin Nasal Spray Reaches Memory Centers in Brain, Offering Hope for Alzheimer Treatment

Hayden E. Klein

The 16-person, first-in-human study showed promising safety and efficacy data for delivering insulin intranasally in older adults.

July 23rd 2025

The Evolving Landscape of Myasthenia Gravis Therapies: A Q&A With Miriam Freimer, MD

Maggie L. Shaw Miriam Freimer, MD

Miriam Freimer, MD, clinical professor of neurology at The Ohio State University Wexner Medical Center, reflects on how findings from the RAISE-XT trial potentially translate to real-world practice and looks to the future of treatment for the autoimmune neuromuscular disorder.